Tobacco company levy could raise up to £4.9bn and prevent 10,000 hospital admissions, study suggests

The UK could raise up to £4.9 billion over five years and significantly improve public health by capping tobacco prices and increasing taxes. 

Research published by the University of Bath Tobacco Control Research Group and the University of Sheffield’s Addictions Research Group, provides the first real-world modelling of a proposed ‘polluter pays’ tobacco levy scheme. 

The study found that the proposed policy, aimed at stopping the tobacco industry from using pricing as a marketing tool, could raise between £1 billion and £4.9 billion over five years, depending on the level of price cap and how quickly it is introduced.  It could also prevent up to 10,000 hospital admissions and save almost 44,000 years of life over a 20-year period. 

Dr Rob Branston, Co-Director of the University of Bath Tobacco Control Research Group and co-author of the study, said: “By passing the Tobacco and Vapes Act, the UK Government has protected a generation from the harmful effects of smoking. Our research shows there is an opportunity for further leadership by tackling the vast profits of an industry that kills more than half of its long-term users. 

“This proposed policy would bring about multiple wins: it raises a large amount of money for the government, delivers health benefits, and helps the poorest the most.” 

How the ‘Polluter Pays’ levy scheme could work 

The levy could be delivered by setting a maximum wholesale price that the industry could charge for tobacco products, thereby stopping the industry from using price as a promotional tool. To stop shop prices falling, the government would raise taxes to offset falls in wholesale prices. 

Dr Branston adds: “Tobacco prices vary considerably: you can go into a shop and buy 20 cigarettes for about £13, or you can pay almost £20 – and those cigarettes are equally as harmful. If you introduce a polluter pays levy and then charge them all at £20, not only will fewer people be able to afford to smoke, but you'd also likely gain more tax revenue for the government. Crucially, that tax revenue will come from the profits of the tobacco industry rather than from people who smoke or small retailers.” 

The idea of a polluter pays levy has been championed by health organisations including ASH (UK), Cancer Research UK, STOP, the All-Party Parliamentary Group on Smoking and Health, and has featured in political manifestos, but has until now remained theoretical. 

The University of Sheffield team, from the Sheffield Addictions Research Group (SARG), led a dynamic micro-simulation modelling exercise for England, tracking 250,000 individuals aged 18 to 89. The analysis explored six scenarios, varying the stringency and speed of tobacco price cap implementation, and built on earlier research by SARG which informed alcohol minimum unit pricing in Scotland. 

 Across the six scenarios, a wholesale price cap and associated tax rises were investigated, comparing outcomes against a business-as-usual scenario. Outcomes varied with the price cap level and speed of implementation, with lower caps and higher tax rises yielding larger changes in consumer behaviour, particularly for the most disadvantaged 20% of the population. 

An immediate hard cap in England could generate £4.9 billion by 2029 and, by 2044, lead to 1,636 fewer deaths, 43,987 fewer years of life lost, and 10,073 fewer hospital admissions.  

Dr Duncan Gillespie, Senior Research Fellow at the University of Sheffield’s School of Medicine and Population Health, and lead author of the study, said:  “Across all six scenarios we modelled, we saw a consistent pattern: a narrower price range in the market, reduced smoking prevalence, higher tax revenues, and fewer deaths and hospital admissions. While industry revenues declined, consumer expenditure remained largely unchanged, showing that meaningful improvements in public health can be achieved without placing an additional financial burden on consumers.”   

Hazel Cheeseman, Chief Executive of Action on Smoking and Health (UK), said:  
“There is overwhelming public support for making tobacco companies pay for the harm their products cause. A ‘polluter pays’ levy reflects a clear public mandate to shift the cost burden away from taxpayers and onto an industry that profits from addiction and disease. 

“As smoking rates fall, those who continue to smoke are increasingly people facing the greatest disadvantage, who bear the heaviest burden of tobacco harm. This makes it even more important that funding is targeted where it’s most needed, to support people to quit and reduce health inequalities. 

“With the Tobacco and Vapes Act now in place to create a smokefree generation, Ministers should now consult on introducing this levy as a sustainable way to resource the action needed to make the country smokefree within the next 20 years.” 

The research paper Reducing tobacco supplier profits and pricing power: Modelling the impact of a tobacco price cap and tax increase on socioeconomic inequalities in England is published in Social Science & Medicine (DOI: 10.1016/j.socscimed.2026.119325). 

The research was funded by The UK Prevention Partnership through the SPECTRUM Consortium, Bloomberg Philanthropies, as part of the Bloomberg Initiative to Reduce Tobacco Use (www.bloomberg.org), and Action on Smoking and Health (UK). Dr Gillespie and Professor Brennan are also members of the Local Health and Global Profits consortium. 

The Tobacco Control Research Group and Local Health and Global Profits are both part of the University of Bath-led Centre for 21st Century Public Health, which focuses on the commercial, political, economic and social determinants of health with the aim of improving health, wellbeing and equity at scale. 

ENDS 

For more information or to request interviews, contact Will McManus in the University of Bath press office: wem25@bath.ac.uk / +44(0)1225 385 798 / press@bath.ac.uk  

About the University of Bath 

The University of Bath is one of the UK's leading universities, recognised for high-impact research, excellence in education, an outstanding student experience and strong graduate prospects. 

• We are ranked among the top 10% of universities globally, placing 132nd in the QS World University Rankings 2026. 

• We are ranked in the top 10 in all of the UK’s major university guides. 

• The University achieved a triple Gold award in the last Teaching Excellence Framework 2023, the highest awards possible, for both the overall assessment and for student outcomes and student experience. The Teaching Excellence Framework (TEF) is a national scheme run by the Office for Students (OfS). 

• We are The Times and The Sunday Times Sport University of the Year 2026. 

• Research at Bath is shaping a better future through innovation in sustainability, health, and digital technologies. Find out all about our Research with Impact: http://bit.ly/3ISz1Wu 

The Tobacco Control Research Group 

The Tobacco Control Research Group (TCRG) is a multidisciplinary, international research group at the University of Bath and part of the Centre for 21st Century Public Health. TCRG works to examine how companies influence health and policy; and evaluate and provide evidence for policy change. 

TCRG is funded by Bloomberg Philanthropies as part of the Bloomberg Initiative to Reduce Tobacco Use (BI). 

Local Health and Global Profits (LHGP) 

Local Health and Global Profits (LHGP) is a research consortium working with local governments and civil society groups to better understand and address the commercial and closely inter-related social, economic, and political factors that impact our health. It is funded by UK Research and Innovation (UKRI) as part of Population Health Improvement UK (PHI UK).